Ozempic Gets a Mention at the Oscars

HOLLYWOOD, CALIFORNIA - MARCH 12: Host Jimmy Kimmel speaks onstage during the 95th Annual Academy Awards at Dolby Theatre on March 12, 2023 in Hollywood, California. (Photo by Kevin Winter/Getty Images)

In the ultimate inevitability, Ozempic received a mention at the 2023 Oscars. Following months of discourse surrounding the off-label weight-loss medication rising in popularity, Jimmy Kimmel gave it a name-drop in his opening monologue at the award show on March 12. “Everybody looks so great,” he said. “When I look around this room, I can’t help but wonder, ‘Is Ozempic right for me?'”

The joke was another gutsy jab from the host, especially considering the speculation around which public figures are on Ozempic. In fact, a New York Magazine cover story published days prior to the Oscars chronicled the drug’s rise on social media and in celebrity circles.

Despite its reputation, Ozempic isn’t explicitly a weight-loss drug. The brand name for semaglutide, Ozempic was approved by the Food and Drug Administration as an injection for adults with type 2 diabetes, and it helps regulate blood-sugar levels. It’s now, however, being touted as a miracle dug because it “prevents and reduces calorie overdose,” Daniel Boyer, MD, told POPSUGAR, “by suppressing appetite and reducing the preference for foods high in fats.” Some fear its growing off-label use could lead to shortages that may affect those who need the drug most.

With it now being mentioned during Hollywood’s biggest night, Ozempic is likely to stick around the news cycle for quite some time. Pace yourselves accordingly.

Products You May Like

Articles You May Like

Carla Rockmore Is Showing Us How to Have Fun With Fashion
Blackpink Visited Buckingham Palace In Royal Fashion
Everything We Know About Beyoncé’s Renaissance Film
24 Best Cyber Monday Shoe Deals You Can Still Shop
Jennifer Lopez and Ben Affleck Go Shopping Over Thanksgiving Weekend

Leave a Reply

Your email address will not be published. Required fields are marked *